UR
Uddaraju Ramprasa Rajendra Varma
About Uddaraju Ramprasa Rajendra Varma
Data last updated:
Uddaraju Ramprasa Rajendra Varma has 24 years in corporate governance. Holds Director role. Currently with 1 company, including Devee Biologicals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Devee Biologicals Private Limited at ₹59.29 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 20 Feb 2002 | 2002 | ₹59.29 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Uddaraju Ramprasa Rajendra Varma
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Uddaraju Ramprasa Rajendra Varma
Uddaraju Ramprasa Rajendra Varma has 24 years in corporate governance. Holds Director role. Currently with 1 company, including Devee Biologicals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Devee Biologicals Private Limited at ₹59.29 Cr (FY 2025).
Uddaraju Ramprasa Rajendra Varma is associated with 1 company as Director, including Devee Biologicals Private Limited (₹59.29 Cr).
Uddaraju Ramprasa Rajendra Varma has expertise in General Business.
Uddaraju Ramprasa Rajendra Varma has 24 years in corporate governance.
By reported revenue, the largest current company of Uddaraju Ramprasa Rajendra Varma is Devee Biologicals Private Limited, with revenue of ₹59.29 Cr (FY 2025).
Uddaraju Ramprasa Rajendra Varma currently holds positions at 1 company: Devee Biologicals Private Limited (₹59.29 Cr).